Videos
Symposium:
Keys to a Proactive and Indivualized anti-VEGF Treatment Approach for nAMD Patients
Interview:
Diagnosing & Tracking Disease Progression with Current Technology
Interview:
Best Practices for
Customising Anti-VEGF
Treatment Protocols
Interview:
Balancing Visual Outcomes
Goals vs. Diagnostic
Outcome Data
Interview:
Audience
Q & A
Podcasts
Podcasts
Part 1
Diagnosing & tracking disease progression with current technology
In the first episode of the EURETINA podcast series on nAMD Treatment Fundamentals Drs. Jean-Francois Korobelnik and Sebastian Waldstein talk about best practices for diagnosing and tracking nAMD disease progression with modern diagnostic tools. To hear the entire interview, make sure to listen to the remaining two podcasts in this series. Independent medical education support provided by Bayer and Zeiss.
Podcasts
Part 2
Best practices for customising anti-VEGF treatment protocols
In the second episode of the EURETINA podcast series on nAMD Treatment Fundamentals Drs. Jean-Francois Korobelnik and Sebastian Waldstein discuss best practices for customizing anti-VEGF treatment protocols. To hear the entire interview, make sure to listen to the remaining two podcasts in this series. Independent medical education support provided by Bayer and Zeiss.
Podcasts
Part 3
In the third episode of the EURETINA podcast series on nAMD Treatment Fundamentals Drs. Jean-Francois Korobelnik and Sebastian Waldstein talk about balancing visual outcome goals with diagnostic outcome data. To hear the entire interview, make sure to listen to the remaining two podcasts in this series. Independent medical education support provided by Bayer and Zeiss.
eLearning
Updates to Anti-VEGF Treatment Dosing
and Duration – Impact on Treatment Protocols
This short course will explore undertreatment in nAMD to better understand its causes and how we can try to reduce it using appropriate protocols.
Balancing Visual Outcome Goals vs. Diagnostic Outcome Data – What’s the more important metric?
This eLearning module helps you to consider the value of visual acuity and diagnostic data in determining the effect of anti-VEGF therapy.
Diagnostic Imaging and How to Track nAMD Disease Progression with Current Technology
This short course examines diagnostic imaging and how to track nAMD disease progression with current technology.
Independent medical education support provided by
Bayer | Roche | Zeiss